EP3139936A4 - Immunkompatible amnionmembranprodukte - Google Patents

Immunkompatible amnionmembranprodukte Download PDF

Info

Publication number
EP3139936A4
EP3139936A4 EP14891554.9A EP14891554A EP3139936A4 EP 3139936 A4 EP3139936 A4 EP 3139936A4 EP 14891554 A EP14891554 A EP 14891554A EP 3139936 A4 EP3139936 A4 EP 3139936A4
Authority
EP
European Patent Office
Prior art keywords
amniotic membrane
membrane products
immunocompatible amniotic
immunocompatible
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14891554.9A
Other languages
English (en)
French (fr)
Other versions
EP3139936A1 (de
Inventor
Samson Tom
Alla Danilkovitch
Dana Yoo
Timothy Jansen
Jin-Qiang Kuang
Jennifer Michelle Marconi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osiris Therapeutics Inc
Original Assignee
Osiris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osiris Therapeutics Inc filed Critical Osiris Therapeutics Inc
Publication of EP3139936A1 publication Critical patent/EP3139936A1/de
Publication of EP3139936A4 publication Critical patent/EP3139936A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
EP14891554.9A 2014-05-07 2014-05-07 Immunkompatible amnionmembranprodukte Withdrawn EP3139936A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/037208 WO2015171144A1 (en) 2014-05-07 2014-05-07 Immunocompatible amniotic membrane products

Publications (2)

Publication Number Publication Date
EP3139936A1 EP3139936A1 (de) 2017-03-15
EP3139936A4 true EP3139936A4 (de) 2017-11-15

Family

ID=54392806

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14891554.9A Withdrawn EP3139936A4 (de) 2014-05-07 2014-05-07 Immunkompatible amnionmembranprodukte

Country Status (7)

Country Link
EP (1) EP3139936A4 (de)
JP (1) JP2017514879A (de)
KR (1) KR20170002572A (de)
AU (1) AU2014393404A1 (de)
CA (1) CA2948133A1 (de)
SG (1) SG11201609255XA (de)
WO (1) WO2015171144A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2790436A1 (en) 2010-02-18 2011-08-25 Osiris Therapeutics, Inc. Immunocompatible chorionic membrane products
AU2014393403A1 (en) * 2014-05-07 2016-11-24 Osiris Therapeutics, Inc. Immunocompatible chorionic membrane products
US20160095307A1 (en) 2014-10-07 2016-04-07 NuTech Medical, Inc. Method and composition for hypothermic storage of placental tissue
CA3032160C (en) 2016-08-24 2024-05-28 Arthrex, Inc. Tissue hybrid for use in repairing, reconstructing or regenerating musculoskeletal degenerative processes or injuries
US12246109B2 (en) * 2018-08-30 2025-03-11 Toshiko Yoshida Regeneration of tendon and tendon sheath, restoration material, and use of restoration material
US11511017B2 (en) 2019-03-12 2022-11-29 Arthrex, Inc. Ligament reconstruction
EP4312597A4 (de) * 2021-03-23 2025-01-22 Organogenesis, Inc. Verfahren, kits und zusammensetzungen zur charakterisierung einer entzündungshemmenden reaktion eines produkts

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037903A1 (en) * 1997-02-28 1998-09-03 Tseng Scheffer C G Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
US20020039788A1 (en) * 2000-02-29 2002-04-04 Isseroff Roslyn R. Corneal epithelial graft composites
WO2005021014A1 (fr) * 2003-09-03 2005-03-10 Jiuchang Miao Preparation d'un amnios biologique conservable a temperature ambiante
US20110206776A1 (en) * 2010-02-18 2011-08-25 Samson Tom Methods of manufacture of immunocompatible amniotic membrane products
US8460715B2 (en) * 2006-08-17 2013-06-11 Mimedx Group, Inc. Placental tissue grafts
EP2702871A1 (de) * 2002-03-26 2014-03-05 Anthrogenesis Corporation Kollagenbiogewebe und Verfahren zur Herstellung und Verwendung davon

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2335634A1 (de) * 2000-02-11 2011-06-22 The General Hospital Corporation Photochemische Gewebeverbindung
WO2007023750A1 (ja) * 2005-08-26 2007-03-01 National University Corporation University Of Toyama 乾燥羊膜及び羊膜の乾燥処理方法
WO2011074208A1 (ja) * 2009-12-18 2011-06-23 国立大学法人東北大学 皮膚真皮又は羊膜透明化による角膜移植材料調製法
US8632512B2 (en) * 2010-04-09 2014-01-21 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
AU2014393403A1 (en) * 2014-05-07 2016-11-24 Osiris Therapeutics, Inc. Immunocompatible chorionic membrane products

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037903A1 (en) * 1997-02-28 1998-09-03 Tseng Scheffer C G Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
US20020039788A1 (en) * 2000-02-29 2002-04-04 Isseroff Roslyn R. Corneal epithelial graft composites
EP2702871A1 (de) * 2002-03-26 2014-03-05 Anthrogenesis Corporation Kollagenbiogewebe und Verfahren zur Herstellung und Verwendung davon
WO2005021014A1 (fr) * 2003-09-03 2005-03-10 Jiuchang Miao Preparation d'un amnios biologique conservable a temperature ambiante
US8460715B2 (en) * 2006-08-17 2013-06-11 Mimedx Group, Inc. Placental tissue grafts
US20110206776A1 (en) * 2010-02-18 2011-08-25 Samson Tom Methods of manufacture of immunocompatible amniotic membrane products

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
DANIEL MELLER ET AL: "Amniotic Membrane Transplantation in the Human Eye", DEUTSCHES AERZTEBLATT ONLINE, 8 April 2011 (2011-04-08), XP055473926, DOI: 10.3238/arztebl.2011.0243 *
DATABASE WPI Week 200522, Derwent World Patents Index; AN 2005-214449, XP002774389 *
HENNING THOMASEN ET AL: "Comparison of cryopreserved and air-dried human amniotic membrane for ophthalmologic applications", GRAEFE'S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY ; INCORPORATING GERMAN JOURNAL OF OPHTHALMOLOGY, SPRINGER, BERLIN, DE, vol. 247, no. 12, 20 August 2009 (2009-08-20), pages 1691 - 1700, XP019760263, ISSN: 1435-702X, DOI: 10.1007/S00417-009-1162-Y *
MASOUMEH JORJANI: "properties of the amniotic membrane", 1 January 2008 (2008-01-01), pages 88 - 99, XP055412685, Retrieved from the Internet <URL:http://discovery.ucl.ac.uk/315080/1/v015a07.pdf> [retrieved on 20171004] *
PORTMANN-LANZ ET AL: "Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration", AMERICAN JOURNAL OF OBSTETRICS & GYNECO, MOSBY, ST LOUIS, MO, US, vol. 194, no. 3, 1 March 2006 (2006-03-01), pages 664 - 673, XP005315891, ISSN: 0002-9378, DOI: 10.1016/J.AJOG.2006.01.101 *
RAMA P ET AL: "Further evaluation of amniotic membrane banking for transplantation in ocular surface diseases.", CELL AND TISSUE BANKING 2001, vol. 2, no. 3, 2001, pages 155 - 163, XP009505892, ISSN: 1573-6814 *
See also references of WO2015171144A1 *
THOMAS J KOOB ET AL: "Biological properties of dehydrated human amnion/chorion composite graft: implications for chronic wound healing", INTERNATIONAL WOUND JOURNAL, vol. 10, no. 5, 1 August 2013 (2013-08-01), UK, pages 493 - 500, XP055259480, ISSN: 1742-4801, DOI: 10.1111/iwj.12140 *
UCHINO YUICHI ET AL: "Amniotic membrane immobilized poly(vinyl alcohol) hybrid polymer as an artificial cornea scaffold that supports a stratified and differentiated corneal epithelium", JOURNAL OF BIOMEDICAL MATERIALS RESEARCH. PART B: APPLIED BIOMATER, JOHN WILEY & SONS, HOBOKEN, NJ, US, vol. 81B, no. 1, 1 April 2007 (2007-04-01), pages 201 - 206, XP009131292, ISSN: 1552-4973, DOI: 10.1002/JBM.B.30654 *

Also Published As

Publication number Publication date
AU2014393404A1 (en) 2016-11-24
EP3139936A1 (de) 2017-03-15
KR20170002572A (ko) 2017-01-06
JP2017514879A (ja) 2017-06-08
SG11201609255XA (en) 2016-12-29
WO2015171144A1 (en) 2015-11-12
CA2948133A1 (en) 2015-11-12

Similar Documents

Publication Publication Date Title
EP3095034A4 (de) Internetsicherheitssystem
EP3219488A4 (de) Dekorfolie
EP3238882A4 (de) Produktionssystem
EP3205519A4 (de) Koppler
EP3194153A4 (de) Packsystem
EP3222230A4 (de) Abstandshalter für laminoplastie
EP3219589A4 (de) Strukturelement
EP3139936A4 (de) Immunkompatible amnionmembranprodukte
EP3098679A4 (de) Produktionssystem
EP3139934A4 (de) Immunkompatible chorionmembranprodukte
EP3159150A4 (de) Formsystem
EP3094588A4 (de) System aus schnalle und lasche
EP3232522A4 (de) Schaltanlage
EP3206499A4 (de) Stapelsystem für kuchen
EP3201092A4 (de) Verpackungssystem mit kartonreihung
EP3118980A4 (de) Poly-generationssystem
EP3154141A4 (de) Schaltanlage
EP3200295A4 (de) Schaltanlage
EP2894941B8 (de) Sammelschienen
AU2014905121A0 (en) Mould
AU2014900993A0 (en) Baked product
AU2014905278A0 (en) Membrane
AU2014900852A0 (en) Spacer
AU2014901051A0 (en) Bung
AU2014904776A0 (en) Weldoze

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20161118

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20171017

RIC1 Information provided on ipc code assigned before grant

Ipc: A61L 27/36 20060101ALI20171010BHEP

Ipc: A61K 35/50 20150101AFI20171010BHEP

Ipc: A61P 17/02 20060101ALI20171010BHEP

17Q First examination report despatched

Effective date: 20180615

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190103